cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.xsnvxa
title: Occurrence Download

description: A dataset containing 2349 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Forpus spengeli (Hartlaub, 1885)"
 ]
}

 The dataset includes 2349 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012089-250415084134356/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.46g8am
title: Occurrence Download

description: A dataset containing 10269 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Observaciones de Aves asociadas a investigaciones de la Univerisdad ICESI en el periodo 2014-2019"
 ]
}

 The dataset includes 10269 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012088-250415084134356/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.15294669
title: TUK_AdiposeFattyAcidGWAS_MainAnalysis

description: TwinsUK Adipose Fatty Acid Genome-wide Association Studies Summary Statistics

Main analysis: Adipose fatty acid GWAS sumstats adjusting for age
DOI: 10.5281/zenodo.15499450
title: Semantic Obfuscation in Hormone Therapy and Its Consequences

description: This article strives to expose and clarify persistent linguistic ambiguities in menopausal hormone replacement therapy. With the development of precise language and an integrated understanding of the essential systemic regulatory functions of estrogen and progesterone, clinicians and patients can engage in the common goal of optimized, precision medicine.

The widespread underrecognition of estrogen and progesterone as essential systemic hormones is not due to lack of evidence—it stems from longstanding structural, educational, and linguistic failures in medicine. Historically, women were excluded from biomedical research, and female-specific hormones were categorized narrowly as reproductive modulators. This androcentric framework ignored their broader roles in brain, bone, immune, and cardiovascular health.

The fallout from the Women's Health Initiative (WHI) amplified confusion by attributing risks observed with synthetic progestins (e.g., MPA) to all hormone therapies. Terminological ambiguity—using “estrogen” and “progesterone” interchangeably for synthetic analogsfurther distorted clinical perception. Despite evidence that bioidentical, transdermal hormones behave differently, medical training and regulatory guidance have not adapted.

Moreover, no specialty has assumed full responsibility for systemic hormone replacement. Gynecology focuses on symptoms, endocrinology ignores menopause, and primary care lacks infrastructure to manage nuance. Compounding this, menopause is framed as a natural, inevitable life stage rather than a modifiable endocrine collapse—leading to untreated bone loss, cognitive decline, and immune dysfunction.

Until medicine reframes estrogen and progesterone as central to systemic health—on par with thyroid and adrenal hormones—patients will continue to be misinformed, mismanaged, and underserved.

The language used in menopausal hormone therapy (MHT) has long been a source of clinical confusion, regulatory ambiguity, and public misunderstanding. Terms like "progesterone," "progestin," "hormone replacement therapy (HRT)," and branded drug names such as "PremPro" have obscured critical distinctions in pharmacology, safety, and therapeutic rationale. This semantic ambiguity has distorted risk communication, impaired informed consent, and undermined the integration of bioidentical hormones into mainstream care.
DOI: 10.5281/zenodo.15551104
title: Semantic Obfuscation in Hormone Therapy, and Its Consequences

description: This article strives to expose and clarify persistent linguistic ambiguities in menopausal hormone replacement therapy. With the development of precise language and an integrated understanding of the essential systemic regulatory functions of estrogen and progesterone, clinicians and patients can engage in the common goal of optimized, precision medicine.

The widespread underrecognition of estrogen and progesterone as essential systemic hormones is not due to lack of evidence—it stems from longstanding structural, educational, and linguistic failures in medicine. Historically, women were excluded from biomedical research, and female-specific hormones were categorized narrowly as reproductive modulators. This androcentric framework ignored their broader roles in brain, bone, immune, and cardiovascular health.

The fallout from the Women's Health Initiative (WHI) amplified confusion by attributing risks observed with synthetic progestins (e.g., MPA) to all hormone therapies. Terminological ambiguity—using “estrogen” and “progesterone” interchangeably for synthetic analogsfurther distorted clinical perception. Despite evidence that bioidentical, transdermal hormones behave differently, medical training and regulatory guidance have not adapted.

Moreover, no specialty has assumed full responsibility for systemic hormone replacement. Gynecology focuses on symptoms, endocrinology ignores menopause, and primary care lacks infrastructure to manage nuance. Compounding this, menopause is framed as a natural, inevitable life stage rather than a modifiable endocrine collapse—leading to untreated bone loss, cognitive decline, and immune dysfunction.

Until medicine reframes estrogen and progesterone as central to systemic health—on par with thyroid and adrenal hormones—patients will continue to be misinformed, mismanaged, and underserved.

The language used in menopausal hormone therapy (MHT) has long been a source of clinical confusion, regulatory ambiguity, and public misunderstanding. Terms like "progesterone," "progestin," "hormone replacement therapy (HRT)," and branded drug names such as "PremPro" have obscured critical distinctions in pharmacology, safety, and therapeutic rationale. This semantic ambiguity has distorted risk communication, impaired informed consent, and undermined the integration of bioidentical hormones into mainstream care.
DOI: 10.5281/zenodo.15499449
title: Semantic Obfuscation in Hormone Therapy, and Its Consequences

description: This article strives to expose and clarify persistent linguistic ambiguities in menopausal hormone replacement therapy. With the development of precise language and an integrated understanding of the essential systemic regulatory functions of estrogen and progesterone, clinicians and patients can engage in the common goal of optimized, precision medicine.

The widespread underrecognition of estrogen and progesterone as essential systemic hormones is not due to lack of evidence—it stems from longstanding structural, educational, and linguistic failures in medicine. Historically, women were excluded from biomedical research, and female-specific hormones were categorized narrowly as reproductive modulators. This androcentric framework ignored their broader roles in brain, bone, immune, and cardiovascular health.

The fallout from the Women's Health Initiative (WHI) amplified confusion by attributing risks observed with synthetic progestins (e.g., MPA) to all hormone therapies. Terminological ambiguity—using “estrogen” and “progesterone” interchangeably for synthetic analogsfurther distorted clinical perception. Despite evidence that bioidentical, transdermal hormones behave differently, medical training and regulatory guidance have not adapted.

Moreover, no specialty has assumed full responsibility for systemic hormone replacement. Gynecology focuses on symptoms, endocrinology ignores menopause, and primary care lacks infrastructure to manage nuance. Compounding this, menopause is framed as a natural, inevitable life stage rather than a modifiable endocrine collapse—leading to untreated bone loss, cognitive decline, and immune dysfunction.

Until medicine reframes estrogen and progesterone as central to systemic health—on par with thyroid and adrenal hormones—patients will continue to be misinformed, mismanaged, and underserved.

The language used in menopausal hormone therapy (MHT) has long been a source of clinical confusion, regulatory ambiguity, and public misunderstanding. Terms like "progesterone," "progestin," "hormone replacement therapy (HRT)," and branded drug names such as "PremPro" have obscured critical distinctions in pharmacology, safety, and therapeutic rationale. This semantic ambiguity has distorted risk communication, impaired informed consent, and undermined the integration of bioidentical hormones into mainstream care.
DOI: 10.5281/zenodo.15551192
title: Semantic Obfuscation in Hormone Therapy, and Its Consequences

description: This article strives to expose and clarify persistent linguistic ambiguities in menopausal hormone replacement therapy. With the development of precise language and an integrated understanding of the essential systemic regulatory functions of estrogen and progesterone, clinicians and patients can engage in the common goal of optimized, precision medicine.

The widespread underrecognition of estrogen and progesterone as essential systemic hormones is not due to lack of evidence—it stems from longstanding structural, educational, and linguistic failures in medicine. Historically, women were excluded from biomedical research, and female-specific hormones were categorized narrowly as reproductive modulators. This androcentric framework ignored their broader roles in brain, bone, immune, and cardiovascular health.

The fallout from the Women's Health Initiative (WHI) amplified confusion by attributing risks observed with synthetic progestins (e.g., MPA) to all hormone therapies. Terminological ambiguity—using “estrogen” and “progesterone” interchangeably for synthetic analogsfurther distorted clinical perception. Despite evidence that bioidentical, transdermal hormones behave differently, medical training and regulatory guidance have not adapted.

Moreover, no specialty has assumed full responsibility for systemic hormone replacement. Gynecology focuses on symptoms, endocrinology ignores menopause, and primary care lacks infrastructure to manage nuance. Compounding this, menopause is framed as a natural, inevitable life stage rather than a modifiable endocrine collapse—leading to untreated bone loss, cognitive decline, and immune dysfunction.

Until medicine reframes estrogen and progesterone as central to systemic health—on par with thyroid and adrenal hormones—patients will continue to be misinformed, mismanaged, and underserved.

The language used in menopausal hormone therapy (MHT) has long been a source of clinical confusion, regulatory ambiguity, and public misunderstanding. Terms like "progesterone," "progestin," "hormone replacement therapy (HRT)," and branded drug names such as "PremPro" have obscured critical distinctions in pharmacology, safety, and therapeutic rationale. This semantic ambiguity has distorted risk communication, impaired informed consent, and undermined the integration of bioidentical hormones into mainstream care.
DOI: 10.5281/zenodo.15294670
title: TUK_AdiposeFattyAcidGWAS_MainAnalysis

description: TwinsUK Adipose Fatty Acid Genome-wide Association Studies Summary Statistics

Main analysis: Adipose fatty acid GWAS sumstats adjusting for age
DOI: 10.5281/zenodo.15508761
title: TUK_AdiposeFattyAcidGWAS_SensitivityAnalysis

description: TwinsUK Adipose Fatty Acid Genome-wide Association Studies Summary Statistics

Sensitivity analysis: Adipose fatty acid GWAS sumstats adjusting for (1) age and BMI; (2) age and cell types (adipocytes, macrophages, and microvascular endothelial cell) (2) age, BMI, and cell types (adipocytes, macrophages and microvascular endothelial cell)
DOI: 10.5281/zenodo.15508762
title: TUK_AdiposeFattyAcidGWAS_SensitivityAnalysis

description: TwinsUK Adipose Fatty Acid Genome-wide Association Studies Summary Statistics

Sensitivity analysis: Adipose fatty acid GWAS sumstats adjusting for (1) age and BMI; (2) age and cell types (adipocytes, macrophages, and microvascular endothelial cell) (2) age, BMI, and cell types (adipocytes, macrophages and microvascular endothelial cell)
DOI: 10.15468/dl.vbc78q
title: Occurrence Download

description: A dataset containing 655698 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-3.43847 50.74898,11.00262 50.74898,11.00262 59.42105,-3.43847 59.42105,-3.43847 50.74898))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "IucnRedListCategory is CR",
 "OccurrenceStatus is Present"
 ]
}

 The dataset includes 655698 records from 452 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008925-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.rru4ns
title: Occurrence Download

description: A dataset containing 36596 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Sardina pilchardus",
 "HasCoordinate is true",
 "Geometry POLYGON((-30 -40, 45 -40, 45 75, -30 75, -30 -40))"
 ]
}

 The dataset includes 36596 records from 147 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008972-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18245211
title: BOSHLANGʻICH SINF DARSLARIDA INTERFAOL METODLARDAN SAMARALI FOYDALANISHNING METODIK ASOSLARI

description: Mazkur maqolada boshlangʻich sinf darslarida interfaol metodlardan samarali foydalanishning metodik asoslari yoritilgan. Interfaol metodlarning o‘quvchilarning bilish faolligini oshirish, mustaqil fikrlashini rivojlantirish hamda dars samaradorligini ta’minlashdagi o‘rni tahlil qilingan. Shuningdek, boshlangʻich ta’lim jarayonida qo‘llaniladigan asosiy interfaol metodlar va ularning pedagogik imkoniyatlari ochib berilgan.
DOI: 10.5281/zenodo.18245212
title: BOSHLANGʻICH SINF DARSLARIDA INTERFAOL METODLARDAN SAMARALI FOYDALANISHNING METODIK ASOSLARI

description: Mazkur maqolada boshlangʻich sinf darslarida interfaol metodlardan samarali foydalanishning metodik asoslari yoritilgan. Interfaol metodlarning o‘quvchilarning bilish faolligini oshirish, mustaqil fikrlashini rivojlantirish hamda dars samaradorligini ta’minlashdagi o‘rni tahlil qilingan. Shuningdek, boshlangʻich ta’lim jarayonida qo‘llaniladigan asosiy interfaol metodlar va ularning pedagogik imkoniyatlari ochib berilgan.
DOI: 10.5281/zenodo.18245231
title: Astragalus L. In: Marchesi E., Mailhos A. & Bonifacino J.M. (Eds.). Flora Uruguaya: Flora Vascular del Uruguay. ISSN 3121-2050, V. 1.0.

description: Citable snapshot. Includes PDF and CSV of collections. Date: January 13th, 2026 at 16:42
DOI: 10.5281/zenodo.18245230
title: Astragalus L. In: Marchesi E., Mailhos A. & Bonifacino J.M. (Eds.). Flora Uruguaya: Flora Vascular del Uruguay. ISSN 3121-2050, V. 1.0.

description: Citable snapshot. Includes PDF and CSV of collections. Date: January 13th, 2026 at 16:42
DOI: 10.15468/dl.by5uec
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{"type":"and","predicates":[{"type":"equals","key":"GADM_LEVEL_2_GID","value":"USA.26.96_1","matchCase":false},{"type":"equals","key":"CLASS_KEY","value":"212","matchCase":false},{"type":"greaterThanOrEquals","key":"YEAR","value":"2015","matchCase":false},{"type":"not","predicate":{"type":"in","key":"BASIS_OF_RECORD","values":["MATERIAL_CITATION","MATERIAL_SAMPLE","PRESERVED_SPECIMEN"],"matchCase":false}},{"type":"lessThanOrEquals","key":"COORDINATE_UNCERTAINTY_IN_METERS","value":"10000","matchCase":false},{"type":"equals","key":"LICENSE","value":"CC BY 4.0","matchCase":false}]}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008974-260108223611665/datasets/export for details.
DOI: 10.15468/dl.jdmkxn
title: Occurrence Download

description: A dataset containing 228 species occurrences available in GBIF matching the query:
{
 "and" : [
 "OccurrenceStatus is Present",
 "TaxonKey is Hydrolagus trolli"
 ]
}

 The dataset includes 228 records from 16 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008975-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.cevg4d
title: Occurrence Download

description: A dataset containing 18585 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Amphipod species in European marine waters"
 ]
}

 The dataset includes 18585 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0008973-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18245237
title: Astragalus distinens Macloskie. In: Marchesi E., Mailhos A. & Bonifacino J.M. (Eds.). Flora Uruguaya: Flora Vascular del Uruguay. ISSN 3121-2050, V. 1.0.

description: Citable snapshot. Includes PDF and CSV of collections. Date: January 13th, 2026 at 16:42
DOI: 10.5281/zenodo.18245238
title: Astragalus distinens Macloskie. In: Marchesi E., Mailhos A. & Bonifacino J.M. (Eds.). Flora Uruguaya: Flora Vascular del Uruguay. ISSN 3121-2050, V. 1.0.

description: Citable snapshot. Includes PDF and CSV of collections. Date: January 13th, 2026 at 16:42
DOI: 10.5519/qd.whic06ph
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (604 records)
DOI: 10.12757/bbk.bopf2025q2.01
title: Bundesbank Online Panel - Firms (BOP-F)

description: Self-administered questionnaire: Web-based
description: The sample for the survey is drawn from the universe of firms based in Germany with a taxable turnover of more than €22,000 or at least one employer subject to social security contributions which includes roughly 1 million firms.
description: The drawing is a proportional random sample according to industry, region and size class, so that the selection probability is equal for all firms.
DOI: 10.15468/sfmt9p
title: New data on the genus Megadiestramima Storozhenko & Gorochov, 1992 (Orthoptera: Rhaphidophoridae: Aemodogryllinae), with descriptions of a new subgenus and a new species from Thailand

description: This dataset contains the digitized treatments in Plazi based on the original journal article Dawwrueng, Pattarawich, Gorochov, Andrei V., Pawangkhanant, Parinya, Suwannapoom, Chatmongkon (2025): New data on the genus Megadiestramima Storozhenko & Gorochov, 1992 (Orthoptera: Rhaphidophoridae: Aemodogryllinae), with descriptions of a new subgenus and a new species from Thailand. Zootaxa 5715 (1): 137-142, DOI: 10.11646/zootaxa.5715.1.10, URL: https://doi.org/10.11646/zootaxa.5715.1.10AbstractThe new subgenus and species Megadiestramima (Troglodiestramima) storozhenkoi subgen. & sp. nov. are described from western Thailand. This new subgenus is easily distinguished by the male seventh abdominal tergite with a shortly broad medial process, the posterior edge of this process with numerous small denticles, and the male paraprocts elongate and triangular as well as without any specialized apex. Its female is similar to the subgenus Leodiestramima in the genital plate with an angular posteromedian process, but the ovipositor apex differs from that of all other subgenera by having small denticles on the ventral edge. We also provide an additional record of Megadiestramima (Leodiestramima) lecta Gorochov, 1998 from Ratchaburi Province and some data on its biology.
DOI: 10.17630/669d3a71-47a8-40c6-be79-3863ea381c23
title: A trade-off between efficiency and stability in a class of sky-blue OLEDs (dataset)

description: The open data folder includes three sub-folders: Characterization, Stress-Testing and Simulations, and the Origin file with all plots.
The Characterization folder includes raw data from JVL (.txt), CV measurements (.txt), EL spectra (.asc).
The Stress-Testing folder includes three sub-folders: LT, Luminance and JV. The LT folder includes the raw data of all lifetime measurements (.txt). The Luminance folder contains the raw data of luminance decays over stress-testing measurements (.txt). The JV folder contains the raw data of JVs acquired during stress testing (.txt).
The Simulations folder contains 2 sub-folders: Stress-Testing and Coupled. The Stress-Testing folder contains Setfos parameter files for all electrical simulations (.parx). The Coupled folder contains Setfos parameter files for all coupled simulations (.parx).
DOI: 10.5281/zenodo.18244574
title: Trust_as_Commons: Why Trust Matters for Community Health Insurance and UHC

description: Complete replication data for manuscript "Why Trust Matters for Community Health Insurance and Universal Health Coverage" (submitted for publication, 2026). This repository contains: • 169 community-based health insurance schemes (1986-2012) across 54 countries • Trust measurements for 216 countries from World Values Survey and regional barometers (2012-2022) • Complete source documentation and attribution for all data points • Replication code for all analyses and main figures Key finding: National levels of generalized trust predict community health insurance scheme sustainability with a correlation of r=0.83 (p<0.001), demonstrating that trust is a fundamental prerequisite for cooperative risk-pooling in informal sector contexts. All data are derived from publicly available sources with complete methodology documentation enabling independent replication and validation of findings. The repository includes three core datasets (schemes_dataset.csv, countries_dataset.csv, trust_data_sources.csv), comprehensive documentation (TRUST_DATA_EXTRACTION.md), and analysis scripts (R code). This dataset supports a manuscript currently under peer review. The repository is journal-neutral and will serve the research regardless of publication venue.

Data collection period: 1986-2022 Analysis period: 2024-2025 Geographic coverage: Global (emphasis on low- and middle-income countries) The repository includes: - schemes_dataset.csv: 169 schemes with operational details and sustainability outcomes - countries_dataset.csv: 216 countries with trust measurements - trust_data_sources.csv: Complete source attribution for 54 countries - TRUST_DATA_EXTRACTION.md: Detailed methodology for trust data extraction - create_figure_1.R: Replication code for main visualization - README.md: Comprehensive documentation with replication instructions - LICENSE.txt: CC BY 4.0 license terms All trust data extracted from: World Values Survey Wave 7, Afrobarometer Round 7, Latinobarómetro 2018, Asian Barometer Wave 4, Arab Barometer Wave 5. Scheme documentation compiled from academic literature, organizational reports, and government evaluations spanning three decades of community health insurance research. This repository enables complete replication of all analyses and findings reported in the manuscript.